http://www.unboundmedicine.com/medline/ebm/research/EpzicomUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19632951/full_citation/Unboosted_Atazanavir_Plus_Co_formulated_Lamivudine/Abacavir_as_a_Ritonavir_Sparing_Simplification_Strategy_in_Routine_Clinical_Practice_Santos JR, Moltó J, Llibre JM, et al. 
Unboosted Atazanavir Plus Co-formulated Lamivudine/Abacavir as a Ritonavir-Sparing Simplification Strategy in Routine Clinical Practice. [Journal Article]
HIV Clin Trials 2009 May-Jun; 10(3):129-34.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19487177/full_citation/Long_Term_Efficacy_and_Safety_of_Fosamprenavir_plus_Ritonavir_Versus_Lopinavir/Ritonavir_in_Combination_with_Abacavir/Lamivudine_over_144_Weeks_Pulido , Estrada , Baril , et al. 
Long-Term Efficacy and Safety of Fosamprenavir plus Ritonavir Versus Lopinavir/Ritonavir in Combination with Abacavir/Lamivudine over 144 Weeks. [Journal Article]
HIV Clin Trials 2009 Mar-Apr; 10(2):76-87.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19487176/full_citation/Virologic_response_and_safety_of_the_abacavir/lamivudine_fixed_dose_formulation_as_part_of_highly_active_antiretroviral_therapy:_analyses_of_six_clinical_studies_Ha B, Liao QM, Dix LP, et al. 
Virologic response and safety of the abacavir/lamivudine fixed-dose formulation as part of highly active antiretroviral therapy: analyses of six clinical studies. [Journal Article]
HIV Clin Trials 2009 Mar-Apr; 10(2):65-75.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19040127/full_citation/[Two_novel_fixed_formulations_of_nucleoside_analogues__tenofovir_emtricitabine_and_abacavir_lamivudine___Prospective_open_study_on_clinical_practice_and_therapeutic_perspectives_in_patients_naïve_and_in_subjects_pre_treated_with_antiretrovirals]Manfredi R, Calza L 
[Two novel fixed formulations of nucleoside analogues (tenofovir-emtricitabine, and abacavir-lamivudine). Prospective, open study on clinical practice and therapeutic perspectives, in patients naïve and in subjects pre-treated with antiretrovirals] [English Abstract, Journal Article]
Recenti Prog Med 2008 Oct; 99(10):492-501.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/18771052/full_citation/Incidence_of_abacavir_hypersensitivity_reactions_in_euroSIDA_Bannister WP, Friis-Møller N, Mocroft A, et al. 
Incidence of abacavir hypersensitivity reactions in euroSIDA. [Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't]
Antivir Ther 2008; 13(5):687-96.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/18387889/full_citation/HIV_study_yields_unexpected_preliminary_efficacy_results_Traynor K 
HIV study yields unexpected preliminary efficacy results. [News]
Am J Health Syst Pharm 2008 Apr 15; 65(8):686-8.
Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/18294111/full_citation/Short_term_safety_and_tolerability_of_a_once_daily_fixed_dose_abacavir_lamivudine_combination_versus_twice_daily_dosing_of_abacavir_and_lamivudine_as_separate_components:_findings_from_the_ALOHA_study_Cohen CJ, Kubota M, Brachman PS, et al. 
Short-term safety and tolerability of a once-daily fixed-dose abacavir-lamivudine combination versus twice-daily dosing of abacavir and lamivudine as separate components: findings from the ALOHA study. [Clinical Trial, Phase III, Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't]
Pharmacotherapy 2008 Mar; 28(3):314-22.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/17219621/full_citation/Advisory_issued_for_Epzicom_Advisory issued for Epzicom. [News]
AIDS Patient Care STDS 2006 Dec; 20(12):888-9.
Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/17051551/full_citation/Hepatitis_B_in_liver_transplant_recipients_Gish RG, McCashland T 
Hepatitis B in liver transplant recipients. [JOURNAL ARTICLE]
Liver Transpl 2006 Oct 18; 12(S2):S54-S64.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/16863488/full_citation/An_update_and_review_of_antiretroviral_therapy_Piacenti FJ 
An update and review of antiretroviral therapy. [Journal Article]
Pharmacotherapy 2006 Aug; 26(8):1111-33.
Abstract | Full Citation | Find Related Articles